This inventor holds 2 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Brain Biotech Ag, Societe Des Produits Nestle S.a.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bickenbach, DE (2021)
- Bickenach, DE (2021)
Company Filing History:
Years Active: 2021
Title: Alexander Pelzer: Innovator in Serine Protease Production
Introduction
Alexander Pelzer is a notable inventor based in Bickenbach, Germany. He has made significant contributions to the field of biotechnology, particularly in the optimization of serine proteases. His innovative methods have the potential to enhance the production of these important enzymes, which play crucial roles in various biological processes.
Latest Patents
Pelzer holds a patent for the "Optimization of the expression of serine proteases in host cells." This invention relates to a method for the recombinant production of a serine protease. The method involves culturing a host cell that contains vectors encoding the serine protease and a proteinaceous inhibitor. The invention also includes the use of CRISPR technology to introduce coding sequences into the host cell genome, allowing for efficient expression and isolation of the serine protease.
Career Highlights
Throughout his career, Alexander Pelzer has worked with several prominent companies in the biotechnology sector. Notable among these are Brain Biotech AG and Weissbiotech GmbH. His experience in these organizations has contributed to his expertise in the field and has facilitated his innovative work.
Collaborations
Pelzer has collaborated with several professionals in his field, including Bela Kelety and Johannes De Bie. These collaborations have likely enriched his research and development efforts, leading to advancements in serine protease production.
Conclusion
Alexander Pelzer is a distinguished inventor whose work in optimizing serine protease production has significant implications for biotechnology. His innovative methods and collaborations highlight his commitment to advancing this important field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
